BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Koo YX, Tan DS, Tan IB, Quek R, Tao M, Lim ST. “Anti-HBc alone” in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients. World J Gastroenterol 2009; 15(30): 3834-3835 [PMID: 19673031 DOI: 10.3748/wjg.15.3834]
URL: https://www.wjgnet.com/1007-9327/full/v15/i30/3834.htm
Number Citing Articles
1
Sourav Sen, Shakti Prasad Panda, K Shanmuganandan, RM Gupta, AK Praharaj. Prevalence of occult hepatitis B amongst Indian human immunodeficiency virus type 1 infected individuals—a pilot studyMedical Journal Armed Forces India 2012; 68(1): 16 doi: 10.1016/S0377-1237(11)60127-5
2
Xiao Nan, Shuang Shi, Canqing Yu, Hui Zhuang. Meta‐analysis of the association between anti‐HBc seropositivity and a poor prognosis of chronic HCV infectionHepatology Research 2010; 40(12): 1176 doi: 10.1111/j.1872-034X.2010.00733.x
3
Hiroyuki Gatanaga, Tsunefusa Hayashida, Junko Tanuma, Shinichi Oka. Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus InfectionClinical Infectious Diseases 2013; 56(12): 1812 doi: 10.1093/cid/cit145
4
Jessica P. Hwang, John M. Vierling, Andrew D. Zelenetz, Susan C. Lackey, Rohit Loomba. Hepatitis B virus management to prevent reactivation after chemotherapy: a reviewSupportive Care in Cancer 2012; 20(11): 2999 doi: 10.1007/s00520-012-1576-7
5
S. K. Basnayake, P. J. Easterbrook. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literatureJournal of Viral Hepatitis 2016; 23(7): 545 doi: 10.1111/jvh.12519